Share Price and Basic Stock Data
Last Updated: December 20, 2025, 2:51 am
| PEG Ratio | 7.37 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Timken India Ltd, a prominent player in the bearings industry, has showcased a commendable growth trajectory over recent years. For the fiscal year ending March 2025, the company reported revenue from operations of ₹3,148 Cr, a significant increase from ₹2,910 Cr in the previous year. This upward trend in sales is particularly noteworthy when considered against the broader context of the manufacturing sector’s recovery post-pandemic. The quarterly sales figures reveal a robust performance, with the latest quarter (June 2025) recording ₹809 Cr, reflecting a consistent demand for its products. However, sales did witness fluctuations throughout the previous quarters, peaking at ₹940 Cr in March 2025 before settling back in subsequent months. This volatility could indicate seasonal demand or supply chain challenges, which may affect future revenue stability. Overall, the revenue growth reflects Timken’s solid market positioning and the increasing reliance on high-quality bearing solutions across various industries.
Profitability and Efficiency Metrics
When examining Timken’s profitability, the company reported a net profit of ₹447 Cr for FY 2025, up from ₹392 Cr the previous year, showcasing a promising growth rate. The operating profit margin (OPM) stood at 19%, which, although slightly lower than the previous year’s 20%, remains competitive within the industry. The return on equity (ROE) was recorded at 15.72%, indicating effective utilization of shareholders’ funds, while the return on capital employed (ROCE) was a healthy 19.11%. However, the high P/E ratio of 51.2 may suggest that the stock is priced for perfection, which could deter some value-focused investors. The company’s efficiency metrics, including a cash conversion cycle (CCC) of 129 days, appear manageable, though it reflects a slight increase from previous years. Timken’s ability to maintain profitability amidst fluctuating expenses and revenues is commendable, but the declining OPM trend raises questions about cost management in a potentially inflationary environment.
Balance Sheet Strength and Financial Ratios
Timken India boasts a robust balance sheet, highlighted by total assets of ₹3,425 Cr against negligible borrowings of just ₹15 Cr. This positions the company with a virtually debt-free status, allowing for greater financial flexibility and lower interest expenses. The interest coverage ratio (ICR) is an impressive 149.64x, reflecting a strong capacity to service any potential debt obligations. Additionally, the book value per share has shown steady growth, now standing at ₹378.21, which complements the company’s healthy reserves of ₹2,770 Cr. The current ratio of 3.82 indicates a comfortable liquidity position, suggesting that Timken can meet its short-term liabilities without difficulty. However, the price-to-book value ratio of 7.27x may suggest that the stock is trading at a premium, which could be a concern for risk-averse investors. Overall, Timken appears well-positioned to weather economic fluctuations, but the high valuation metrics may require careful consideration.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Timken India reflects a stable foundation of investor confidence. Promoters hold a significant 51.05% stake, which provides a strong alignment with shareholder interests. Institutional investors, including domestic and foreign entities, collectively own approximately 37.11%, indicating robust institutional interest in the company. Notably, foreign institutional investors (FIIs) have increased their stake from 6.56% in June 2023 to 9.44% in June 2025, signaling growing confidence in Timken’s prospects. The public holding has remained relatively stable, accounting for about 11.84%. However, the decline in promoter holding from 67.80% in December 2022 to the current level may raise eyebrows regarding insider confidence. While the institutional backing is encouraging, the reduction in promoter stakes could be perceived as a risk, prompting potential investors to dig deeper into the reasons behind this shift.
Outlook, Risks, and Final Insight
Looking ahead, Timken India faces both opportunities and challenges. The increasing demand for high-quality bearings, particularly in sectors like automotive and renewable energy, presents a favorable backdrop for growth. However, the company must navigate potential headwinds, including raw material price volatility and supply chain disruptions, which could impact its margins and overall profitability. Additionally, the high valuation metrics may pose a risk if earnings growth does not meet investor expectations. As the market evolves, Timken’s ability to innovate and adapt to changing customer needs will be crucial. Investors should weigh the strong financial fundamentals and growth potential against the elevated valuations and potential operational risks. A cautious approach, focusing on both the company’s solid performance and the broader economic landscape, will be essential for making informed investment decisions in Timken India Ltd.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Galaxy Bearings Ltd | 186 Cr. | 586 | 1,125/571 | 30.5 | 337 | 0.00 % | 16.1 % | 13.6 % | 10.0 |
| Deccan Bearings Ltd | 332 Cr. | 166 | 166/81.2 | 8.79 | 0.00 % | 107 % | 107 % | 10.0 | |
| Benara Bearings & Pistons Ltd | 17.3 Cr. | 9.78 | 24.4/9.77 | 4.73 | 0.00 % | 26.1 % | 512 % | 10.0 | |
| Austin Engineering Company Ltd | 45.3 Cr. | 130 | 206/128 | 10.4 | 198 | 0.00 % | 8.04 % | 6.00 % | 10.0 |
| Timken India Ltd | 22,812 Cr. | 3,033 | 3,576/2,200 | 50.2 | 368 | 1.19 % | 20.9 % | 17.0 % | 10.0 |
| Industry Average | 13,606.57 Cr | 1,098.86 | 30.24 | 216.54 | 0.69% | 29.53% | 80.37% | 7.22 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 699 | 695 | 609 | 803 | 718 | 682 | 612 | 898 | 784 | 753 | 671 | 940 | 809 |
| Expenses | 528 | 563 | 506 | 650 | 582 | 546 | 510 | 699 | 643 | 620 | 565 | 730 | 666 |
| Operating Profit | 172 | 132 | 104 | 153 | 136 | 136 | 102 | 199 | 141 | 133 | 107 | 210 | 142 |
| OPM % | 25% | 19% | 17% | 19% | 19% | 20% | 17% | 22% | 18% | 18% | 16% | 22% | 18% |
| Other Income | 11 | 22 | 14 | 7 | 9 | 10 | 11 | 11 | 12 | 12 | 13 | 14 | 10 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 22 | 22 | 22 | 21 | 21 | 21 | 21 | 22 | 22 | 21 | 21 | 21 | 21 |
| Profit before tax | 160 | 131 | 95 | 137 | 123 | 124 | 91 | 187 | 130 | 124 | 98 | 202 | 130 |
| Tax % | 26% | 26% | 26% | 24% | 27% | 25% | 26% | 24% | 26% | 27% | 24% | 7% | 20% |
| Net Profit | 118 | 98 | 71 | 105 | 90 | 93 | 68 | 141 | 96 | 90 | 74 | 187 | 104 |
| EPS in Rs | 15.70 | 12.98 | 9.38 | 13.89 | 11.98 | 12.37 | 8.98 | 18.80 | 12.80 | 11.96 | 9.88 | 24.84 | 13.86 |
Last Updated: August 1, 2025, 10:10 am
Below is a detailed analysis of the quarterly data for Timken India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 809.00 Cr.. The value appears to be declining and may need further review. It has decreased from 940.00 Cr. (Mar 2025) to 809.00 Cr., marking a decrease of 131.00 Cr..
- For Expenses, as of Jun 2025, the value is 666.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 730.00 Cr. (Mar 2025) to 666.00 Cr., marking a decrease of 64.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 142.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 68.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 18.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 4.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 130.00 Cr.. The value appears to be declining and may need further review. It has decreased from 202.00 Cr. (Mar 2025) to 130.00 Cr., marking a decrease of 72.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be increasing, which may not be favorable. It has increased from 7.00% (Mar 2025) to 20.00%, marking an increase of 13.00%.
- For Net Profit, as of Jun 2025, the value is 104.00 Cr.. The value appears to be declining and may need further review. It has decreased from 187.00 Cr. (Mar 2025) to 104.00 Cr., marking a decrease of 83.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.86. The value appears to be declining and may need further review. It has decreased from 24.84 (Mar 2025) to 13.86, marking a decrease of 10.98.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 719 | 926 | 1,042 | 1,056 | 1,233 | 1,664 | 1,618 | 1,411 | 2,203 | 2,807 | 2,910 | 3,148 | 3,193 |
| Expenses | 646 | 792 | 880 | 898 | 1,070 | 1,375 | 1,254 | 1,159 | 1,692 | 2,246 | 2,337 | 2,556 | 2,596 |
| Operating Profit | 73 | 134 | 162 | 158 | 163 | 289 | 363 | 252 | 511 | 560 | 572 | 592 | 597 |
| OPM % | 10% | 14% | 16% | 15% | 13% | 17% | 22% | 18% | 23% | 20% | 20% | 19% | 19% |
| Other Income | 10 | 6 | 3 | 10 | 21 | 16 | 23 | 20 | 14 | 53 | 41 | 50 | 47 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 2 | 3 | 4 | 4 | 4 |
| Depreciation | 16 | 17 | 22 | 29 | 43 | 79 | 77 | 75 | 84 | 87 | 85 | 85 | 89 |
| Profit before tax | 66 | 122 | 142 | 138 | 140 | 224 | 306 | 195 | 438 | 524 | 524 | 553 | 550 |
| Tax % | 32% | 34% | 35% | 30% | 34% | 34% | 20% | 27% | 25% | 25% | 25% | 19% | |
| Net Profit | 45 | 81 | 92 | 97 | 92 | 149 | 246 | 143 | 327 | 391 | 392 | 447 | 455 |
| EPS in Rs | 6.58 | 11.87 | 13.50 | 14.29 | 13.53 | 19.76 | 32.72 | 19.04 | 43.49 | 51.95 | 52.13 | 59.48 | 60.47 |
| Dividend Payout % | 99% | 25% | 7% | 7% | 7% | 5% | 153% | 8% | 3% | 3% | 5% | 61% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.00% | 13.58% | 5.43% | -5.15% | 61.96% | 65.10% | -41.87% | 128.67% | 19.57% | 0.26% | 14.03% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.42% | -8.15% | -10.59% | 67.11% | 3.14% | -106.97% | 170.54% | -109.10% | -19.32% | 13.77% |
Timken India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 14% |
| 3 Years: | 13% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 13% |
| 3 Years: | 11% |
| TTM: | 14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 20% |
| 3 Years: | -4% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:46 pm
Balance Sheet
Last Updated: December 4, 2025, 2:07 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 68 | 68 | 68 | 68 | 68 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| Reserves | 314 | 370 | 462 | 550 | 634 | 1,266 | 1,501 | 1,268 | 1,582 | 1,962 | 2,342 | 2,770 | 2,693 |
| Borrowings | 3 | 3 | 4 | 8 | 16 | 23 | 24 | 35 | 32 | 31 | 25 | 17 | 15 |
| Other Liabilities | 114 | 144 | 168 | 251 | 261 | 411 | 377 | 510 | 505 | 489 | 545 | 564 | 598 |
| Total Liabilities | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
| Fixed Assets | 97 | 107 | 137 | 231 | 251 | 795 | 748 | 818 | 860 | 843 | 853 | 809 | 1,265 |
| CWIP | 26 | 27 | 21 | 58 | 54 | 64 | 157 | 97 | 50 | 53 | 104 | 592 | 241 |
| Investments | 23 | 17 | 38 | 91 | 55 | 176 | 13 | 0 | 99 | 236 | 161 | 117 | 120 |
| Other Assets | 354 | 435 | 506 | 498 | 619 | 741 | 1,060 | 973 | 1,185 | 1,424 | 1,870 | 1,908 | 1,756 |
| Total Assets | 500 | 585 | 702 | 877 | 979 | 1,775 | 1,977 | 1,888 | 2,194 | 2,557 | 2,988 | 3,425 | 3,382 |
Below is a detailed analysis of the balance sheet data for Timken India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 75.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 75.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,693.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,770.00 Cr. (Mar 2025) to 2,693.00 Cr., marking a decrease of 77.00 Cr..
- For Borrowings, as of Sep 2025, the value is 15.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 17.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 598.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 564.00 Cr. (Mar 2025) to 598.00 Cr., marking an increase of 34.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,265.00 Cr.. The value appears strong and on an upward trend. It has increased from 809.00 Cr. (Mar 2025) to 1,265.00 Cr., marking an increase of 456.00 Cr..
- For CWIP, as of Sep 2025, the value is 241.00 Cr.. The value appears to be declining and may need further review. It has decreased from 592.00 Cr. (Mar 2025) to 241.00 Cr., marking a decrease of 351.00 Cr..
- For Investments, as of Sep 2025, the value is 120.00 Cr.. The value appears strong and on an upward trend. It has increased from 117.00 Cr. (Mar 2025) to 120.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,756.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,908.00 Cr. (Mar 2025) to 1,756.00 Cr., marking a decrease of 152.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,382.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,425.00 Cr. (Mar 2025) to 3,382.00 Cr., marking a decrease of 43.00 Cr..
Notably, the Reserves (2,693.00 Cr.) exceed the Borrowings (15.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 70.00 | 131.00 | 158.00 | 150.00 | 147.00 | 266.00 | 339.00 | 217.00 | 479.00 | 529.00 | 547.00 | 575.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 75 | 69 | 68 | 66 | 66 | 66 | 66 | 96 | 89 | 75 | 82 | 81 |
| Inventory Days | 112 | 110 | 108 | 111 | 121 | 125 | 124 | 171 | 171 | 125 | 142 | 124 |
| Days Payable | 60 | 57 | 65 | 92 | 97 | 92 | 92 | 156 | 100 | 76 | 82 | 76 |
| Cash Conversion Cycle | 128 | 122 | 110 | 85 | 90 | 99 | 98 | 112 | 160 | 124 | 142 | 129 |
| Working Capital Days | 104 | 98 | 91 | 70 | 96 | 80 | 74 | 86 | 117 | 102 | 111 | 107 |
| ROCE % | 19% | 30% | 30% | 24% | 21% | 22% | 21% | 13% | 29% | 28% | 23% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Mid Cap Fund | 2,193,640 | 0.75 | 691.96 | 2,150,287 | 2025-12-14 00:38:48 | 2.02% |
| HDFC Small Cap Fund | 1,715,839 | 1.42 | 541.24 | 1,635,876 | 2025-12-14 13:37:58 | 4.89% |
| Nippon India Small Cap Fund | 1,184,218 | 0.54 | 373.55 | 1,134,218 | 2025-11-02 18:14:38 | 4.41% |
| Mirae Asset Large Cap Fund | 805,394 | 0.61 | 254.05 | 682,131 | 2025-10-30 01:21:09 | 18.07% |
| Nippon India Multi Cap Fund | 765,286 | 0.48 | 241.4 | N/A | N/A | N/A |
| Nippon India Growth Mid Cap Fund | 646,271 | 0.48 | 203.86 | N/A | N/A | N/A |
| Mirae Asset ELSS Tax Saver Fund | 584,528 | 0.68 | 184.38 | 469,585 | 2025-12-15 00:57:48 | 24.48% |
| SBI Large & Midcap Fund | 560,000 | 0.48 | 176.65 | 595,174 | 2025-10-30 01:21:09 | -5.91% |
| ICICI Prudential Smallcap Fund | 522,836 | 1.95 | 164.92 | 520,855 | 2025-12-14 01:36:52 | 0.38% |
| Invesco India Contra Fund | 480,033 | 0.74 | 151.42 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Diluted EPS (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| Cash EPS (Rs.) | 70.75 | 63.46 | 63.54 | 54.70 | 28.99 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 378.21 | 321.36 | 270.83 | 220.28 | 178.61 |
| Dividend / Share (Rs.) | 36.00 | 2.50 | 1.50 | 1.50 | 1.50 |
| Revenue From Operations / Share (Rs.) | 418.49 | 386.81 | 373.13 | 292.91 | 187.52 |
| PBDIT / Share (Rs.) | 85.32 | 81.52 | 81.57 | 69.79 | 36.08 |
| PBIT / Share (Rs.) | 74.05 | 70.19 | 69.97 | 58.58 | 26.12 |
| PBT / Share (Rs.) | 73.48 | 69.69 | 69.60 | 58.25 | 25.93 |
| Net Profit / Share (Rs.) | 59.48 | 52.13 | 51.95 | 43.49 | 19.03 |
| PBDIT Margin (%) | 20.38 | 21.07 | 21.86 | 23.82 | 19.23 |
| PBIT Margin (%) | 17.69 | 18.14 | 18.75 | 19.99 | 13.93 |
| PBT Margin (%) | 17.55 | 18.01 | 18.65 | 19.88 | 13.82 |
| Net Profit Margin (%) | 14.21 | 13.47 | 13.92 | 14.84 | 10.15 |
| Return on Networth / Equity (%) | 15.72 | 16.22 | 19.18 | 19.74 | 10.65 |
| Return on Capital Employeed (%) | 19.11 | 20.99 | 24.71 | 25.06 | 13.54 |
| Return On Assets (%) | 13.06 | 13.12 | 15.28 | 14.91 | 7.58 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.98 | 1.05 | 1.18 | 1.08 | 0.72 |
| Current Ratio (X) | 3.82 | 3.91 | 3.77 | 2.89 | 2.16 |
| Quick Ratio (X) | 2.56 | 2.50 | 2.44 | 1.61 | 1.32 |
| Inventory Turnover Ratio (X) | 4.80 | 4.71 | 1.64 | 1.58 | 1.36 |
| Dividend Payout Ratio (NP) (%) | 4.20 | 2.87 | 2.88 | 3.44 | 262.63 |
| Dividend Payout Ratio (CP) (%) | 3.53 | 2.36 | 2.36 | 2.74 | 172.44 |
| Earning Retention Ratio (%) | 95.80 | 97.13 | 97.12 | 96.56 | -162.63 |
| Cash Earning Retention Ratio (%) | 96.47 | 97.64 | 97.64 | 97.26 | -72.44 |
| Interest Coverage Ratio (X) | 149.64 | 161.83 | 218.11 | 214.54 | 188.33 |
| Interest Coverage Ratio (Post Tax) (X) | 105.31 | 104.49 | 139.91 | 134.68 | 100.36 |
| Enterprise Value (Cr.) | 20293.77 | 21146.70 | 20763.57 | 16203.61 | 9597.83 |
| EV / Net Operating Revenue (X) | 6.45 | 7.27 | 7.40 | 7.35 | 6.80 |
| EV / EBITDA (X) | 31.62 | 34.49 | 33.84 | 30.87 | 35.37 |
| MarketCap / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| Retention Ratios (%) | 95.79 | 97.12 | 97.11 | 96.55 | -162.63 |
| Price / BV (X) | 7.27 | 8.88 | 10.26 | 9.77 | 7.25 |
| Price / Net Operating Revenue (X) | 6.57 | 7.38 | 7.45 | 7.35 | 6.90 |
| EarningsYield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
After reviewing the key financial ratios for Timken India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 70.75. This value is within the healthy range. It has increased from 63.46 (Mar 24) to 70.75, marking an increase of 7.29.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 378.21. It has increased from 321.36 (Mar 24) to 378.21, marking an increase of 56.85.
- For Dividend / Share (Rs.), as of Mar 25, the value is 36.00. This value exceeds the healthy maximum of 3. It has increased from 2.50 (Mar 24) to 36.00, marking an increase of 33.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 418.49. It has increased from 386.81 (Mar 24) to 418.49, marking an increase of 31.68.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 85.32. This value is within the healthy range. It has increased from 81.52 (Mar 24) to 85.32, marking an increase of 3.80.
- For PBIT / Share (Rs.), as of Mar 25, the value is 74.05. This value is within the healthy range. It has increased from 70.19 (Mar 24) to 74.05, marking an increase of 3.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 73.48. This value is within the healthy range. It has increased from 69.69 (Mar 24) to 73.48, marking an increase of 3.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 59.48. This value is within the healthy range. It has increased from 52.13 (Mar 24) to 59.48, marking an increase of 7.35.
- For PBDIT Margin (%), as of Mar 25, the value is 20.38. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 20.38, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 17.69. This value is within the healthy range. It has decreased from 18.14 (Mar 24) to 17.69, marking a decrease of 0.45.
- For PBT Margin (%), as of Mar 25, the value is 17.55. This value is within the healthy range. It has decreased from 18.01 (Mar 24) to 17.55, marking a decrease of 0.46.
- For Net Profit Margin (%), as of Mar 25, the value is 14.21. This value exceeds the healthy maximum of 10. It has increased from 13.47 (Mar 24) to 14.21, marking an increase of 0.74.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 15.72, marking a decrease of 0.50.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has decreased from 20.99 (Mar 24) to 19.11, marking a decrease of 1.88.
- For Return On Assets (%), as of Mar 25, the value is 13.06. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 13.06, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has decreased from 1.05 (Mar 24) to 0.98, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has decreased from 3.91 (Mar 24) to 3.82, marking a decrease of 0.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.56. This value exceeds the healthy maximum of 2. It has increased from 2.50 (Mar 24) to 2.56, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.80. This value is within the healthy range. It has increased from 4.71 (Mar 24) to 4.80, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 20. It has increased from 2.87 (Mar 24) to 4.20, marking an increase of 1.33.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.53. This value is below the healthy minimum of 20. It has increased from 2.36 (Mar 24) to 3.53, marking an increase of 1.17.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.80. This value exceeds the healthy maximum of 70. It has decreased from 97.13 (Mar 24) to 95.80, marking a decrease of 1.33.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.47. This value exceeds the healthy maximum of 70. It has decreased from 97.64 (Mar 24) to 96.47, marking a decrease of 1.17.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 149.64. This value is within the healthy range. It has decreased from 161.83 (Mar 24) to 149.64, marking a decrease of 12.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 105.31. This value is within the healthy range. It has increased from 104.49 (Mar 24) to 105.31, marking an increase of 0.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 20,293.77. It has decreased from 21,146.70 (Mar 24) to 20,293.77, marking a decrease of 852.93.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.45. This value exceeds the healthy maximum of 3. It has decreased from 7.27 (Mar 24) to 6.45, marking a decrease of 0.82.
- For EV / EBITDA (X), as of Mar 25, the value is 31.62. This value exceeds the healthy maximum of 15. It has decreased from 34.49 (Mar 24) to 31.62, marking a decrease of 2.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For Retention Ratios (%), as of Mar 25, the value is 95.79. This value exceeds the healthy maximum of 70. It has decreased from 97.12 (Mar 24) to 95.79, marking a decrease of 1.33.
- For Price / BV (X), as of Mar 25, the value is 7.27. This value exceeds the healthy maximum of 3. It has decreased from 8.88 (Mar 24) to 7.27, marking a decrease of 1.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.57. This value exceeds the healthy maximum of 3. It has decreased from 7.38 (Mar 24) to 6.57, marking a decrease of 0.81.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Timken India Ltd:
- Net Profit Margin: 14.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.11% (Industry Average ROCE: 29.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.72% (Industry Average ROE: 80.37%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 105.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.56
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50.2 (Industry average Stock P/E: 30.24)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Bearings | No. 39-42, Electronic City, Phase II, Hosur Road, Bengaluru Karnataka 560100 | tilinvestor@timken.com http://www.timken.com/en-in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sanjay Koul | Chairman & Managing Director |
| Mr. Avishrant Keshava | Whole Time Director |
| Mr. Ajay Sood | Independent Director |
| Mr. George J Ollapally | Independent Director |
| Dr. Lakshmi Lingam | Independent Director |
| Mrs. Soumitra Hazra | Independent Director |
| Mr. Douglas Smith | Director |
| Mr. Hansal Patel | Director |
FAQ
What is the intrinsic value of Timken India Ltd?
Timken India Ltd's intrinsic value (as of 20 December 2025) is 2542.31 which is 16.18% lower the current market price of 3,033.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 22,812 Cr. market cap, FY2025-2026 high/low of 3,576/2,200, reserves of ₹2,693 Cr, and liabilities of 3,382 Cr.
What is the Market Cap of Timken India Ltd?
The Market Cap of Timken India Ltd is 22,812 Cr..
What is the current Stock Price of Timken India Ltd as on 20 December 2025?
The current stock price of Timken India Ltd as on 20 December 2025 is 3,033.
What is the High / Low of Timken India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Timken India Ltd stocks is 3,576/2,200.
What is the Stock P/E of Timken India Ltd?
The Stock P/E of Timken India Ltd is 50.2.
What is the Book Value of Timken India Ltd?
The Book Value of Timken India Ltd is 368.
What is the Dividend Yield of Timken India Ltd?
The Dividend Yield of Timken India Ltd is 1.19 %.
What is the ROCE of Timken India Ltd?
The ROCE of Timken India Ltd is 20.9 %.
What is the ROE of Timken India Ltd?
The ROE of Timken India Ltd is 17.0 %.
What is the Face Value of Timken India Ltd?
The Face Value of Timken India Ltd is 10.0.